GH1 and fatty liver disease: Recently, Collin de l ́Hortet et al. [22] described involvement of reduced GH/epidermal growth factor receptor (EGFR) signaling in diminished liver regeneration capacity in hepatic steatosis which was partly resolved by GH administration.